Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4252-4256

  Yousef, George M ^a,b   Obiezu, Christina V ^a,b   Luo, Liu Ying ^a,b   Black, Margot H ^a   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; KALLIKREIN; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; RNA; SERINE PROTEINASE; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CHROMOSOME 19Q; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BREAST; CHROMOSOME MAPPING; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GONADAL STEROID HORMONES; HUMANS; KALLIKREINS; MALE; MOLECULAR SEQUENCE DATA; PROSTATE; SEQUENCE HOMOLOGY; TUMOR CELLS, CULTURED;

EID: 0033198389     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Birren, B., Green, E. D., Klaphoz, S., Myers, R. N., and Roskams, J. Genome Analysis: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1998.
2. Collins, F. S. Positional cloning: let us not call it reverse anymore. Nat. Genet., 7: 3-6, 1992.
3. Ruddle, F. H. Reverse genetics and beyond. Am. J. Hum. Genet., 6: 944-953, 1984.
4. Ballabio, A. The rise and fall of positional cloning? Nat. Genet., 7: 513-520, 1993.
5. Colliris, J. E., Cole, C. G., Smink, L. J., Garrett, C. L., Leversha, M. A., Soderlund, L. A., Maslen, G. L., Everett, L. A., Rice, K. M., Coffey, A. J., Gregory, S. G., Gwilliam, R., Durham, A., Davies, A. F., Hassock, S., Todd, C. M., Lehrach. H., Huisebos, T. J. M., Weissenbach, J., Morrow, B., Kucheriapati, R. S., Wadey, R., Scambier, P. J., Kim, U-J., Simon, M. I., Peyrard, M., Xie. Y-G., Carter, N. P., Durbin, R., Dumanski, J. P., Bentley, D. R., and Dunham, I. A high-density YAC contig map of human chromosome 22. Nature (Lond.), 377: 367-379, 1995.
6. Evans, B. A., Yun, Z. X., Close, J. A., Tregear, G. W., Kitamura, N., Nakanishi, S., Callen, D. F., Baker, E., Hyland, V. J., Sutherland, G. R., and Richards, R I. Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry, 27: 3124-3129, 1988.
7. Clements, J. The molecular biology of the kallikreins and their roles in inflammation. In: S Farmer (ed.), The Kinin System, pp. 71-97. New York: Academic Press, 1997.
8. Evans, B. A., Drinkwater, C. C., and Richards, R. I. Mouse glandular kallikrein genes: structure and partial sequence analysis of the kallikrein gene locus. J. Biol. Chem., 262: 8027-8034, 1987.
9. Ashley, P. L., and MacDonald, R. J. Tissue-specific expression of kallikrein-related genes in the rat. Biochemistry, 24: 4520-5427, 1985.
10. Riegman, P. H., Vlietstra, R. J., van der Korput, J., Romijn, J. C., and Trapman, J. Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. Biochem. Biophys. Res. Commun., 159: 95-102, 1989.
11. Schedlich, L. J., Bennetts, B. H., and Morris, B. J. Primary structure of a human glandular kallikrein gene. DNA, 6: 429-437, 1987.
12. Rittenhouse, H. G., Finlay, J. A., Mikolajczyk, S. D., and Partin, A. W. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci., 35: 275-368, 1998.
13. Riegman, P. H., Vlietstra, R. J., Suurmeijer L., Cleutjens, C. B., and Trapman, J. Characterization of the human kallikrein locus. Genomics, 14: 6-11, 1992.
14. Anisowicz, A., Sotiropoulou, G., Stenman, G., Mok, S. C., and Sager, R. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol. Med., 2: 624-636, 1996.
15. Little, S. P., Dixon, E. P., Morris, F., Buckley, W., Becker, G. W., Johnson, M., Dobbins, J. R., Wyrick, T., Miller, J. R., Mackellar, W., Hepburn, D., Corralan, J., McClure, D., Liu, X., Stephenson, D., Clemens, J., and Johnstone, E. M. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J. Biol. Chem., 272: 25135-25142, 1997.
16. Yamashiro, K., Tsuruoka, N., Kodama, S., Tsujimoto, M., Yamamura, Y., Tanaka, T., Nakazato, H., and Yamaguchi, N. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim. Biophys. Acta, 1350: 11-14, 1997.
17. Liu, X. L., Wazer, D. E., Watanabe, K., and Band, V. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res., 56: 3371-3379, 1996.
18. Pontes, J. E., Chu, T. M., Slack, N., Karr, J., and Murphy, G. P. Serum prostate antigen measurement in localized prostate cancer: correlation with clinical course. J. Urol., 128: 1216-1218, 1982.
19. Diamandis, E. P. Prostate specific antigen: its usefulness in clinical medicine. Trends Endocrinol. Metab., 9: 310-316, 1998.
20. Black, M. H., Magklara, A., Obiezu, C., Melegos, D. N., and Diamandis, E. P. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross reactivity from prostate specific antigen (PSA). Clin. Chem., 45: 790-799, 1999.
21. Goyal, J., Smith, K. M., Cowan, J. M., Wazer, D. E., Lee, S. W., and Band, V. The role of NES1 serine protease as a novel tumor suppressor. Cancer Res., 58: 4782-4786, 1998.
22. Nelson, P. S., Gan, L., Ferguson, C., Moss, P., Gelinas, R., Hood, L., and Wang, K. Molecular cloning and characterization of prostase, an androgen-regulaled serine protease with prostate-restricted expression. Proc. Natl. Acad. Sci. USA, 96: 3114-3119, 1999.
23. Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res., 25: 3389-3402, 1997.
24. Lennon, G., Auffray, C., Polymeropoulous, M., and Scares, M. B. The I. M. A. G. E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics, 33: 151-152, 1996.
25. Diamandis, E. P., Yu, H., and Sutherland, D. J. Detection of prostate-specific antigen immunoreactivity in breast tumours. Breast Cancer Res. Treat., 32: 301-310, 1994.
26. Ishikawa, T., Kashiwagi, H., Iwakami, Y., Hirai, M., Kawamura, T., Aiyoshi, Y., Yashiro, T., Ami, Y., Uchida, K., and Miwa, M. Expression of α-fetoprotein and prostate specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction. Jpn. J. Oncol., 28: 723-728, 1998.
27. Luo, L., Herbrick, J-A., Scherer, S. W., Beatty, B., Squire, J., and Diamandis, E. P. Structural characterization and mapping of the normal epithelial cell-specific 1 gene. Biochem. Biophys. Res. Commun., 247: 580-586, 1998.
28. Yoshida, S., Taniguchi, M., Hirata, A., and Shiosaka. S. Sequence analysis and expression of human neuropsin cDNA and gene. Gene, 213: 9-16, 1998.
29. Yousef, G. M., Luo, L., and Diamandis, E. P. Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4. Anticancer Res., in press, 1999.
30. Irwin, D. M., Robertson, K. A., and MacGillivary, R. T. Structure and evolution of the bovine prothrombin gene. J. Mol. Biol., 212: 31-45, 1988.
31. Magklara, A., Scorilas, A., López-Otín, C., Vizoso, F., Ruibal, A., and Diamandis, E. P. Human glandular kallikrein (hK2) in breast milk, amniotic fluid and breast cyst fluid. Clin. Chem., in press, 1999.
32. Black, M. H., Magklara, A., Obiezu, C., Levesque, M. A., Sutherland, D. J., Tindall, D. J., Young, C. Y., Sauter, E. R., and Diamandis, E. P. Expression of a prostate-associated protein, human glandular kallikrein (hk2), in breast tumours and in normal breast secretions. Br. J. Cancer, in press, 1999.
33. Zarghami, N., Grass, L., and Diamandis, E. P. Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br. J. Cancer, 75: 579-588, 1997.
34. Yu, H., Levesque, M. A., Clark, G. M., and Diamandis, E. P. Prognostic value of prostate-specific antigen for women with breast cancer. Clin. Cancer Res., 4: 1489-1497, 1998.
35. Sauter, E. R., Daly, M., Linahan, K., Ehya, H., Engstrom, P. F., Bonney, G., Ross, E. A., Yu, H., and Diamandis, E. P. Prostate specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol. Biomark. Prev., 5:967-970, 1996.
36. Balbay, M. D., Juang, P., Llansa, N., Williams, S., McConkey, D., Fidler, I. J., and Pettaway, C. A. Stable transfection of human prostate cancer cell line PC-3 with prostate specific antigen induces apoptosis both in vivo and in vitro. Proc. Am. Assoc. Cancer Res., 40: 225-226, 1999.
37. Lai, L. C., Erbas, H., Lennard, T. W., and Peaston, R. T. Prostate-specific antigen in breast cyst fluid: possible role of prostate specific antigen in hormone-dependent breast cancer, hit. J. Cancer, 66: 743-746, 1996.
38. Kumar, A., Mikolajczyk, S. D., Goel, A. S., Millar, L. S., and Saedi, M. S. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res., 57: 3111-3114, 1997.
39. Lovgren, J., Rajakoski, K., Karp, M., Lundwall, A., and Lilja, H. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem. Biophys. Res. Commun., 238: 549-555, 1997.
40. Takayama, T. K., Fujikawa, K., and Davie, E. W. Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J. Biol. Chem., 272: 21582-21588, 1997.
41. Diamandis, E. P., and Yu, H. New biological functions of prostate specific antigen? J. Clin. Endocrinol. Metab., 80: 1515-1517, 1995.
42. Reifenberger, J., Reifenberger, G., Liu, L., James, C. D., Wechsler, W., and Collins, V. P. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am. J. Pathol., 145: 1175-1190, 1994.
43. Lopez-Otin, C., and Diamandis, E. P. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr. Rev., 19: 365-396, 1998.